BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27808465)

  • 1. Long-term outcomes of 95 children with moderate aplastic anemia treated with horse antithymocyte globulin and cyclosporine.
    Nishikawa E; Yagasaki H; Hama A; Yabe H; Ohara A; Kosaka Y; Kudo K; Kobayashi R; Ohga S; Morimoto A; Watanabe KI; Yoshida N; Muramatsu H; Takahashi Y; Kojima S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27808465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithymocyte globulin and cyclosporine in children with aplastic anemia: a developing country experience.
    Sharma R; Chandra J; Sharma S; Pemde H; Singh V
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):93-5. PubMed ID: 22278201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
    Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
    Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine.
    Scheinberg P; Wu CO; Nunez O; Young NS
    J Pediatr; 2008 Dec; 153(6):814-9. PubMed ID: 18672253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATG-Fresenius S combined with cyclosporine a: an effective immunosuppressive therapy for children with aplastic anemia.
    Luo CJ; Gao YJ; Tang JY; Zhu XH; Xue HL; Lu FJ; Pan C; Jiang H; Luo CY; Ye QD; Zhou M; Chen J
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):374-8. PubMed ID: 24807005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study using tacrolimus rather than cyclosporine plus antithymocyte globulin as an immunosuppressive therapy regimen option for severe aplastic anemia in adults.
    Zhu X; Guan J; Xu J; Wei J; Jiang L; Yin J; Zhao L; Zhang Y
    Blood Cells Mol Dis; 2014 Sep; 53(3):157-60. PubMed ID: 24931461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
    Jeong DC; Chung NG; Cho B; Zou Y; Ruan M; Takahashi Y; Muramatsu H; Ohara A; Kosaka Y; Yang W; Kim HK; Zhu X; Kojima S
    Haematologica; 2014 Apr; 99(4):664-71. PubMed ID: 24213150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
    Pongtanakul B; Das PK; Charpentier K; Dror Y
    Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.
    Marsh J; Schrezenmeier H; Marin P; Ilhan O; Ljungman P; McCann S; Socie G; Tichelli A; Passweg J; Hows J; Raghavachar A; Locasciulli A; Bacigalupo A
    Blood; 1999 Apr; 93(7):2191-5. PubMed ID: 10090926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination of rabbit antithymocyte globulin and cyclosporine A as first-line therapy for adult severe aplastic anemia].
    Cao HM; Wang HJ; Zhang L; Jing LP; Zhou K; Yang DL; Li HQ; Liu QG; Yan ZS; Liu YZ; Wu YH; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):38-42. PubMed ID: 21429400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit antithymocyte globulin treatment in childhood acquired severe aplastic anemia.
    Karapinar DY; Karadaş N; Ay Y; Akin M; Balkan C; Aydinok Y; Kavakli K
    Pediatr Hematol Oncol; 2014 Feb; 31(1):20-8. PubMed ID: 23627541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of severe aplastic anemia in children using standardized immunosuppressive therapy with antithymocyte globulin and cyclosporine A.
    Goldenberg NA; Graham DK; Liang X; Hays T
    Pediatr Blood Cancer; 2004 Dec; 43(7):718-22. PubMed ID: 15390303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
    Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
    Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
    Chen C; Fang JP; Huang SL; Zhong FY
    Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre.
    Shen Y; Li Y; Liu Q; Liu W; Yu Q; Hu H; Liu S; Dong J; Xu M; Hong Y; Chen Y; Deng S; Zhuang H; Hu Z; Lin S; Shen Y; Shen J; Zhou Y; Ye B; Wu D
    Ann Med; 2023; 55(2):2271475. PubMed ID: 37871262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.